|
| 37939105 | Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial. | Clin Cancer Res | 2024 |
| 38057686 | Presence of crown-like structures in breast adipose tissue; differences between healthy controls, BRCA1/2 gene mutation carriers and breast cancer patients. | Breast Cancer Res Treat | 2024 |
| 36622544 | Assessing the role of tumour-associated macrophage subsets in breast cancer subtypes using digital image analysis. | Breast Cancer Res Treat | 2023 |
| 37635223 | Correction: Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer. | J Exp Clin Cancer Res | 2023 |
| 37223262 | Molecular imaging as biomarker for treatment response and outcome in breast cancer. | Ther Adv Med Oncol | 2023 |
| 37280675 | Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer. | J Exp Clin Cancer Res | 2023 |
| 37310797 | Quality of Life in Male Breast Cancer: Prospective Study of the International Male Breast Cancer Program (EORTC10085/TBCRC029/BIG2-07/NABCG). | Oncologist | 2023 |
| 37038006 | PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trial. | Nat Cancer | 2023 |
| 35096909 | ERANET JTC 2011: Submission and Activation of an International Academic Translational Project in Advanced Breast Cancer. Experience From the ET-FES Study. | Front Med (Lausanne) | 2022 |
| 35584346 | Clinical Validity of 16α-[<sup>18</sup>F]Fluoro-17β-Estradiol Positron Emission Tomography/Computed Tomography to Assess Estrogen Receptor Status in Newly Diagnosed Metastatic Breast Cancer. | J Clin Oncol | 2022 |
| 35601798 | Proton therapy of a pregnant patient with nasopharyngeal carcinoma. | Clin Transl Radiat Oncol | 2022 |
| 35362794 | First-time imaging of [<sup>89</sup>Zr]trastuzumab in breast cancer using a long axial field-of-view PET/CT scanner. | Eur J Nucl Med Mol Imaging | 2022 |
| 35871138 | Validation of the 70-gene signature test (MammaPrint) to identify patients with breast cancer aged ⿥ 70 years with ultralow risk of distant recurrence: A population-based cohort study. | J Geriatr Oncol | 2022 |
| 32817140 | Assessment of Bone Lesions with <sup>18</sup>F-FDG PET Compared with <sup>99m</sup>Tc Bone Scintigraphy Leads to Clinically Relevant Differences in Metastatic Breast Cancer Management. | J Nucl Med | 2021 |
| 33506375 | Population Pharmacokinetics of Docetaxel, Paclitaxel, Doxorubicin and Epirubicin in Pregnant Women with Cancer: A Study from the International Network of Cancer, Infertility and Pregnancy (INCIP). | Clin Pharmacokinet | 2021 |
| 34976826 | Radiolabeled Monoclonal Antibody Against Colony-Stimulating Factor 1 Receptor Specifically Distributes to the Spleen and Liver in Immunocompetent Mice. | Front Oncol | 2021 |
| 34829366 | Analyzing the Estrogen Receptor Status of Liver Metastases with [<sup>18</sup>F]-FES-PET in Patients with Breast Cancer. | Diagnostics (Basel) | 2021 |
| 33990400 | Value of <sup>18</sup>F-FES PET in Solving Clinical Dilemmas in Breast Cancer Patients: A Retrospective Study. | J Nucl Med | 2021 |
| 34312396 | Evaluation of multiple transcriptomic gene risk signatures in male breast cancer. | NPJ Breast Cancer | 2021 |
| 34023558 | Effects of supervised exercise during adjuvant endocrine therapy in overweight or obese patients with breast cancer: The I-MOVE study. | Breast | 2021 |
| 33341447 | Serial [<sup>18</sup>F]-FDHT-PET to predict bicalutamide efficacy in patients with androgen receptor positive metastatic breast cancer. | Eur J Cancer | 2021 |
| 33181752 | Detection of Dural Metastases Before the Onset of Clinical Symptoms by 16α-[18F]Fluoro-17β-Estradiol PET in a Patient With Estrogen Receptor-Positive Breast Cancer. | Clin Nucl Med | 2021 |
| 31511981 | Distress, problems, referral wish, and supportive health care use in breast cancer survivors beyond the first year after chemotherapy completion. | Support Care Cancer | 2020 |
| 31999296 | High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes: 20-Year Follow-up of a Phase 3 Randomized Clinical Trial. | JAMA Oncol | 2020 |
| 31891878 | Molecular imaging to identify patients with metastatic breast cancer who benefit from endocrine treatment combined with cyclin-dependent kinase inhibition. | Eur J Cancer | 2020 |
| 31653758 | Expression of hypoxia-induced proteins in ductal carcinoma in situ and invasive cancer of the male breast. | J Clin Pathol | 2020 |
| 32627087 | Application of PET Tracers in Molecular Imaging for Breast Cancer. | Curr Oncol Rep | 2020 |
| 32964114 | Cyclin E expression is associated with high levels of replication stress in triple-negative breast cancer. | NPJ Breast Cancer | 2020 |
| 32993099 | Image Quality and Interpretation of [<sup>18</sup>F]-FES-PET: Is There any Effect of Food Intake? | Diagnostics (Basel) | 2020 |
| 32990883 | Fluorescent image-guided surgery in breast cancer by intravenous application of a quenched fluorescence activity-based probe for cysteine cathepsins in a syngeneic mouse model. | EJNMMI Res | 2020 |
| 32188473 | High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer. | Breast Cancer Res | 2020 |
| 32217763 | Preclinical PET imaging of bispecific antibody ERY974 targeting CD3 and glypican 3 reveals that tumor uptake correlates to T cell infiltrate. | J Immunother Cancer | 2020 |
| 32182822 | Loss of Y-Chromosome during Male Breast Carcinogenesis. | Cancers (Basel) | 2020 |
| 32307594 | Visual and quantitative evaluation of [<sup>18</sup>F]FES and [<sup>18</sup>F]FDHT PET in patients with metastatic breast cancer: an interobserver variability study. | EJNMMI Res | 2020 |
| 32367253 | Clinical utility of circulating tumor DNA as a response and follow-up marker in cancer therapy. | Cancer Metastasis Rev | 2020 |
| 30745297 | <sup>89</sup>Zr-labeled Bispecific T-cell Engager AMG 211 PET Shows AMG 211 Accumulation in CD3-rich Tissues and Clear, Heterogeneous Tumor Uptake. | Clin Cancer Res | 2019 |
| 31283631 | Decalcification of Breast Cancer Bone Metastases With EDTA Does Not Affect ER, PR, and HER2 Results. | Am J Surg Pathol | 2019 |
| 31444658 | Enhanced pulmonary uptake on <sup>18</sup>F-FES-PET/CT scans after irradiation of the thoracic area: related to fibrosis? | EJNMMI Res | 2019 |
| 31077689 | Consideration of breast cancer subtype in targeting the androgen receptor. | Pharmacol Ther | 2019 |
| 28589637 | Performance of BRCA1/2 mutation prediction models in male breast cancer patients. | Clin Genet | 2018 |
| 30214621 | Comparative biodistribution analysis across four different <sup>89</sup>Zr-monoclonal antibody tracers-The first step towards an imaging warehouse. | Theranostics | 2018 |
| 30208359 | Androgen receptor expression inversely correlates with immune cell infiltration in human epidermal growth factor receptor 2-positive breast cancer. | Eur J Cancer | 2018 |
| 30149225 | Considering the biology of late recurrences in selecting patients for extended endocrine therapy in breast cancer. | Cancer Treat Rev | 2018 |
| 30227299 | Tumor-associated macrophages in breast cancer: Innocent bystander or important player? | Cancer Treat Rev | 2018 |
| 29980531 | Molecular Imaging of Radiolabeled Bispecific T-Cell Engager <sup>89</sup>Zr-AMG211 Targeting CEA-Positive Tumors. | Clin Cancer Res | 2018 |
| 30058029 | <sup>89</sup>Zr-trastuzumab PET supports clinical decision making in breast cancer patients, when HER2 status cannot be determined by standard work up. | Eur J Nucl Med Mol Imaging | 2018 |
| 30005963 | Micro-computed tomography (micro-CT) for intraoperative surgical margin assessment of breast cancer: A feasibility study in breast conserving surgery. | Eur J Surg Oncol | 2018 |
| 30478423 | <sup>89</sup>Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer. | Nat Med | 2018 |
| 29602822 | <sup>18</sup>F-Fluoroestradiol Tumor Uptake Is Heterogeneous and Influenced by Site of Metastasis in Breast Cancer Patients. | J Nucl Med | 2018 |
| 29482783 | Evolution in sentinel lymph node biopsy in breast cancer. | Crit Rev Oncol Hematol | 2018 |